11-Dideuterolinoleic acid
11-Dideuterolinoleic acid Basic information
- Product Name:
- 11-Dideuterolinoleic acid
- Synonyms:
-
- 11-Dideuterolinoleic acid
- Balixafortide (POL6326
- POL-6326)
- Cyclo[L-alanyl-L-cysteinyl-L-seryl-L-alanyl-D-prolyl-(2S)-2,4-diaminobutanoyl-L-arginyl-L-tyrosyl-L-cysteinyl-L-tyrosyl-L-glutaminyl-L-lysyl-D-prolyl-L-prolyl-L-tyrosyl-L-histidyl], cyclic (2→9)-disulfide
- Balixafortide TFA salt
- Balixafortide(POL6326) (free base)
- POL6326 (Balixafortide) TFA salt
- CAS:
- 1051366-32-5
- MF:
- C84H118N24O21S2
- MW:
- 1864.11
- Mol File:
- 1051366-32-5.mol
11-Dideuterolinoleic acid Chemical Properties
- Density
- 1.58±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO:100.0(Max Conc. mg/mL);45.33(Max Conc. mM)
Water:100.0(Max Conc. mg/mL);45.33(Max Conc. mM) - pka
- 9.89±0.15(Predicted)
- Water Solubility
- Water: 100 mg/mL (53.64 mM);
- Sequence
- H-Ala-Cys-Ser-Ala-Pro-Arg-Tyr-Cys-Tyr-Gln-Lys-Pro-Pro-Tyr-His-OH(Disulfide bridges Cys-Cys)
11-Dideuterolinoleic acid Usage And Synthesis
Uses
Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2].
in vivo
Balixafortide is optimized for favorable mouse absorption, distribution, metabolism and excretion (ADME) properties with balanced plasma protein binding, greater plasma and microsomal stability[1].
IC 50
CXCR4: <10 nM (IC50)
References
[1] Zimmermann J, et al. Anti-tumor cell activity and in vitro profile of the next generation CXCR4 antagonist Balixafortide. Ann Oncol. 2018 Oct;29 Suppl 8:viii103.
[2] Karpova D, et al. Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial. J Transl Med. 2017 Jan 3;15(1):2. DOI:10.1186/s12967-016-1107-2
11-Dideuterolinoleic acidSupplier
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 010-50973130 18101056239
- 3193328036@qq.com
- Tel
- 0571-87213919
- Eric@peptidego.com
- Tel
- +1-2135480471
- sales@sarms4muscle.com